Radioisotope developer MDS Nordion of Kanata, Ontario, said it has established four centers of excellence in Europe for its liver cancer treatment product, TheraSphere.
The facilities, where the company will educate healthcare professionals on the use of the treatment system, are the BCLC Group Hospital Clinic in Barcelona, Spain; the Centre Eugene Marquis in Rennes, France; the University-Hospital Essen in Germany; and the University of Pisa in Italy.
By AuntMinnie.com staff writers
February 8, 2007
Related Reading
MDS Nordion shows Q4 revenue downturn, year-end upturn, December 14, 2006
MDS sells diagnostics unit, October 5, 2006
MDS Nordion gets FDA OK for TheraSphere clinical trials, September 26, 2006
MDS Nordion Q3 posts flat revenues, September 7, 2006
MDS Nordion Q2 shows gains, June 8, 2006
Copyright © 2007 AuntMinnie.com